Latest news
Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.
Ceftriaxone-resistant gonorrhoea is no longer only being imported into Europe. ECDC has found evidence of domestic transmission. The window to keep first-line treatment effective is still open, but it will close if testing and follow-up remain optional
NTDs Are Now A Human-Rights Issue. Budgets Must Follow.
Europe Can Forecast Vibrio Risk. It Still Has To Act.
Cardiology has too many dashboards. The danger is forgetting the patient
GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up
A CE Mark Is Not Access
Europe Opens the SMA Gene-Therapy Door Wider
ALS Needs Proof, Not Just Another Biomarker
Pregnancy complications demand long-term cardiovascular care
MENA’s cardiometabolic crisis is a stability issue
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.